Human Competitors

Stocks . Israel . 
Stock . Human Xtensions
HUMX Stock  ILA 27.10  0.80  3.04%   
Human Xtensions competes with Intercure, Sofwave Medical, Epitomee Medical, Bio View, and Elbit Imaging; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Human Xtensions competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Human Xtensions to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Human Xtensions Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Human Xtensions competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
22.2027.1032.00
Details
Intrinsic
Valuation
LowRealHigh
21.1226.0230.92
Details
Naive
Forecast
LowNextHigh
25.5830.4835.38
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
26.0826.8327.59
Details

Human Xtensions Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Human Xtensions and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Human and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Human Xtensions does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
INSL
+ 0.73
INCR
EMITF
+ 0.69
EPIT
BIOV
+ 0.59
EPIT
EMITF
+ 0.55
SOFW
EPIT
+ 0.5
SOFW
BIOV
+ 0.49
SOFW
  
High negative correlations   
EMITF
- 0.79
INCR
EPIT
- 0.68
INCR
INSL
- 0.65
EMITF
INSL
- 0.62
EPIT
ENDY
- 0.61
BIOV
SOFW
- 0.44
INCR

Risk-Adjusted Indicators

There is a big difference between Human Stock performing well and Human Xtensions Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Human Xtensions' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Human Xtensions Competitive Analysis

The better you understand Human Xtensions competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Human Xtensions' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Human Xtensions' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
HUMX INCR SOFW EPIT BIOV EMITF INSL ENDY
 3.04 
 27.10 
Human
 5.46 
 498.20 
Intercure
 0.33 
 1,797 
Sofwave
 3.33 
 938.20 
Epitomee
 1.91 
 26.70 
Bio
 0.21 
 512.90 
Elbit
 3.96 
 210.00 
Insuline
 4.10 
 302.00 
Endymed
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Weak
OK
Very Weak
Solid
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Average
Low
Below Average
Low
Low
Below Average
Below Average
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
16.84 X
0.31 X
N/A
N/A
2.14 X
0.29 X
0.98 X
2.58 X
Net Asset
N/A
686.32 M
N/A
N/A
40.02 M
72.27 M
1.58 M
19.6 M
Profit Margin
N/A
0.09 %
(0.61) %
N/A
0.04 %
N/A
N/A
0.14 %
EBITDA
(45.95 M)
31.18 M
(15.14 M)
N/A
4.72 M
(20.43 M)
(6.82 M)
3.2 M
Operating Margin
(14.93) %
0.18 %
(0.62) %
N/A
0.02 %
(2.36) %
N/A
0.06 %
Current Valuation
(47.61 M)
688.06 M
174.37 M
339.18 M
35.4 M
335.88 M
N/A
1.85 M
Price To Book
0.27 X
1.43 X
2.19 X
3.48 X
1.72 X
0.73 X
N/A
0.70 X
Retained Earnings
N/A
(35 M)
N/A
N/A
(29 M)
(267 M)
(158 M)
(12 M)
Current Asset
N/A
1000 K
N/A
N/A
26 M
249 M
8 M
9 M
Beta
1.26
-0.22
N/A
N/A
0.53
0.89
1.79
-0.0864
Number Of Employees
72
350
92
6
35
4
26
41
Shares Outstanding
26.76 M
45.57 M
34.15 M
29.58 M
13.75 M
9.19 M
N/A
13.76 M
Cash Flow From Operations
(27.26 M)
25.02 M
N/A
N/A
3.25 M
(3.38 M)
(7.68 M)
4.63 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
0.09 %
N/A
N/A
Total Debt
7.55 M
11.95 M
N/A
N/A
2.57 M
280.59 M
N/A
463 K
Return On Equity
-0.5
0.0736
-0.35
N/A
0.0399
-0.25
N/A
0.21
Z Score
1.8
27.6
N/A
N/A
12.0
-9.0
N/A
46.6
Return On Asset
-0.27
0.0538
-0.18
N/A
0.0091
-0.0522
N/A
0.0385
Book Value Per Share
2.67 X
10.75 X
1.12 X
N/A
2.00 X
7.72 X
(0.16) X
1.04 X
Current Liabilities
N/A
1000 K
N/A
N/A
8 M
595 M
9 M
4 M
Total Asset
N/A
686.32 M
N/A
N/A
40.02 M
72.27 M
1.58 M
19.6 M
Debt To Equity
0.05 %
64.90 %
N/A
N/A
11.80 %
N/A
N/A
7.10 %
Target Price
N/A
40.23
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
0.5
N/A
N/A
Shares Owned By Institutions
9.62 %
11.60 %
22.84 %
20.28 %
N/A
6.25 %
N/A
N/A
Market Capitalization
28.63 M
551.89 M
392.36 M
318.32 M
53.86 M
51.49 M
36.33 M
35.42 M
Price To Earning
N/A
590.59 X
N/A
N/A
N/A
(40.77) X
(40.77) X
N/A
Price To Sales
6.20 X
1.87 X
10.41 X
N/A
1.71 X
16.72 X
N/A
1.52 X
Net Income
(28.54 M)
4.69 M
N/A
N/A
2.18 M
(20.5 M)
(7.01 M)
5.16 M
Earnings Per Share
(2.01) X
0.74 X
(0.29) X
N/A
0.09 X
(2.24) X
(30.78) X
0.74 X
Shares Owned By Insiders
55.22 %
37.64 %
53.24 %
56.83 %
51.58 %
28.90 %
N/A
58.11 %
Revenue
3.12 M
219.68 M
25.33 M
N/A
30.51 M
N/A
40 K
21.78 M
Working Capital
N/A
N/A
N/A
N/A
18 M
(346 M)
(1000 K)
5 M
Cash And Equivalents
148.31 M
3.66 M
N/A
N/A
17.67 M
42.11 M
1.15 M
5.02 M
Cash Per Share
5.56 X
0.04 X
N/A
N/A
1.24 X
4.58 X
2.86 X
0.39 X
Gross Profit
1.62 M
102.56 M
16.21 M
N/A
17.59 M
N/A
N/A
10.06 M
Day Typical Price
27.37
504.33
1794.0
938.33
26.3
511.93
210.0
302.0
Accumulation Distribution
0.0634
0.0356
0.0116
0.0344
0.0449
0.0057
N/A
N/A
Market Facilitation Index
1.8
18.4
21.0
32.8
1.2
2.9
N/A
N/A
Daily Balance Of Power
0.4444
(1.57)
(0.29)
0.9207
0.4167
(0.38)
9.2 T
9.2 T
Period Momentum Indicator
0.8
(28.80)
(6.00)
30.2
0.5
(1.10)
8.0
11.9
Rate Of Daily Change
1.03
0.95
1.0
1.03
1.02
1.0
1.04
1.04
Day Median Price
27.5
507.4
1792.5
938.4
26.1
511.45
210.0
302.0
Price Action Indicator
N/A
(23.60)
1.5
14.9
0.85
0.9
4.0
5.95
Relative Strength Index
43.83
8.89
68.02
28.73
80.52
93.98
9.59
12.9
Coefficient Of Variation
(2,948)
(404.80)
3311.49
851.97
2795.72
658.55
(1,573)
2491.16
Mean Deviation
3.87
2.65
1.56
10.33
2.86
1.98
2.59
2.71
Jensen Alpha
(0.16)
(0.81)
0.0839
3.48
0.1908
0.5306
(0.57)
0.1816
Total Risk Alpha
(1.40)
(1.36)
(0.33)
(1.28)
(0.51)
(0.03)
(1.13)
(0.73)
Sortino Ratio
N/A
N/A
(0.02)
0.6366
0.0038
0.1091
N/A
0.0255
Downside Variance
N/A
N/A
8.25
31.95
15.8
8.79
N/A
20.05
Standard Deviation
7.25
3.35
2.51
31.77
4.08
2.99
5.08
6.11
Kurtosis
18.19
(0.17)
3.2
58.29
1.87
2.2
4.64
35.12
Potential Upside
8.04
4.91
5.16
23.06
7.92
6.06
10.17
4.1
Treynor Ratio
0.3337
3.97
(0.44)
1.89
(0.30)
(0.62)
(0.17)
0.5306
Maximum Drawdown
57.26
14.45
14.75
273.98
22.33
16.02
33.39
47.62
Variance
52.59
11.22
6.31
1009.13
16.62
8.94
25.82
37.28
Market Risk Adjusted Performance
0.3437
3.98
(0.43)
1.9
(0.29)
(0.61)
(0.16)
0.5406
Risk Adjusted Performance
(0.02)
(0.18)
0.0301
0.0998
0.0356
0.1239
(0.04)
0.0395
Skewness
3.01
(0.24)
(0.51)
7.43
(0.03)
0.3632
(0.46)
4.89
Semi Deviation
N/A
N/A
2.53
4.29
3.52
2.11
N/A
3.43
Information Ratio
(0.05)
(0.29)
(0.02)
0.1133
0.0037
0.1081
(0.09)
0.0187
Value At Risk
(11.24)
(5.76)
(3.74)
(7.13)
(4.95)
(4.00)
(9.52)
(6.46)
Expected Short fall
N/A
N/A
(1.59)
(16.42)
(3.77)
(2.66)
N/A
(3.55)
Downside Deviation
N/A
N/A
2.87
5.65
3.97
2.96
N/A
4.48
Semi Variance
N/A
N/A
6.42
18.44
12.41
4.47
N/A
11.78

Human Xtensions Competition Performance Charts

Five steps to successful analysis of Human Xtensions Competition

Human Xtensions' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Human Xtensions in relation to its competition. Human Xtensions' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Human Xtensions in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Human Xtensions' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Human Xtensions, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Human Xtensions position

In addition to having Human Xtensions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Music and Video Thematic Idea Now

Music and Video
Music and Video Theme
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Human Stock

Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY